DermWORX Professional Skincare and LETI Laboratories announce plans to launch a series of top European dermatological products in the United States.

LETI Laboratories is a strategic founding partner for DermWORX, headquartered in Barcelona, Spain. The partnership includes LETI’s leading dermatology line for atopic skin, AT4, which DermWORX will market to U.S. healthcare professionals and their patients beginning in Q3, 2014.

Future plans include introducing additional LETI lines in the U.S. and potential expansion of DermWORX products internationally. LETI became a DermWORX partner and stakeholder in early 2013.

Jaime Grego, President of LETI, commented:

“DermWORX and LETI share a passion for creating high-quality skin therapeutics and products that improve people’s lives, particularity those with compromised skin. For nearly 100 years, LETI has earned the loyalty of physicians and their patients with safe and effective solutions like AT4. We are thrilled to make these products available in the United States through our partnership with DermWORX.”

Tom Ford, Chief Executive Officer of DermWORX, added:

“We’ve seen how these LETI products have changed patients’ lives in the international market, and it is very exciting to introduce them to our customers in the U.S. medical community. And this is only the beginning. Beyond allergic skin, LETI has a deep portfolio of established skincare solutions that are poised to really make a difference here in the U.S.”